Trial Profile
Impact of high methotrexate dose in combination with adalimumab compared with low MTX dose:Corrona Rheumatoid Arthritis Registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jul 2017
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 03 Jul 2017 New trial record
- 17 Jun 2017 Primary endpoint has been met (Mean change in clinical disease activity index (CDAI), as reported in an abstract presented at the 18th Annual Congress of the European League Against Rheumatism
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism